Stockscreener 앱 받기
25.53
0.41%
0.1046
전일 마감가:
$25.43
열려 있는:
$25.56
하루 거래량:
1,361
Relative Volume:
0.41
시가총액:
$25.02M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
+1.89%
1개월 성능:
-1.03%
6개월 성능:
-1.86%
1년 성능:
-2.98%
1일 변동 폭
$25.53
$25.62
1주일 범위
$25.11
$25.49
52주 변동 폭
$24.98
$27.70
Cencora Inc Stock (CCOR) Company Profile
Compare CCOR vs VOO, IVV, SPY, VTI, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CCOR
Cencora Inc
|
25.53 | 25.02M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
714.79 | 1.05T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
781.08 | 896.29B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
777.62 | 821.27B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
381.41 | 702.48B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
745.69 | 498.72B | 0 | 0 | 0 | 0.00 |
Cencora Inc 주식(CCOR)의 최신 뉴스
5 Best Emerging Markets ETFs for 2026 and How to Invest - The Motley Fool
What are private markets? - BlackRock
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga
Cencora (COR) ex-officer lines up new stock sale - Stock Titan
Cencora (COR) Stock Forecast and Price Target 2026 $COR - MarketBeat
Cencora stock heads into the open after a 0.1% dip - ad-hoc-news.de
Cencora Inc. stock dips after RBC reiterates cautious price target - ad-hoc-news.de
Is Cencora Stock Underperforming the Dow? - inkl
Cencora stock price target maintained at $330 by RBC Capital By Investing.com - Investing.com Australia
Cencora stock heads into the open after a modest decline - ad-hoc-news.de
Cencora stock holds firm after RBC keeps $330 target - ad-hoc-news.de
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora stock price target maintained at $330 by RBC Capital - Investing.com Canada
Cencora stock price target maintained at $330 by RBC Capital - Investing.com India
Cencora stock price target maintained at $330 by RBC Capital - Investing.com
Cencora stock price target maintained at $330 by RBC Capital - Investing.com South Africa
Cencora, Inc. (COR) Stock Analysis: Robust Growth in Medical Distribution with an 11.59% Upside Potential - directorstalkinterviews.com
Cencora Inc. stock gains on solid fiscal 2026 momentum - ad-hoc-news.de
Why Cencora (COR) Is Getting Attention Today - simplywall.st
Cencora stock gains on solid fiscal 2026 earnings momentum - AD HOC NEWS
Cencora’s New Cell and Gene Services Might Change The Case For Investing In Cencora (COR) - simplywall.st
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - finance.yahoo.com
Former Cencora (NYSE: COR) leader lines up another stock sale - Stock Titan
Cencora Inc. stock gains on new cell and gene therapy service and strong guidance - ad-hoc-news.de
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Cencora Launches Cell and Gene Therapy Enablement for Health Systems - finance.yahoo.com
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Yahoo Finance
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
What Cencora (COR)'s Cell and Gene Push and Higher 2026 Outlook Means For Shareholders - finance.yahoo.com
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Eastern Progress
Cencora Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs - BioBuzz
Artisan Sold Cencora (COR) as Earnings Momentum Slowed - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora (NYSE: COR) executive sells 985 shares in preset plan - Stock Titan
Cencora stock gains after guidance increase and resilient Q2 performance - AD HOC NEWS
Cencora Launches Cell and Gene Therapy Enablement Service Through Accelerate Pharmacy Solutions - marketscreener.com
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc. stock reflects insider sale plans and steady growth outlook - ad-hoc-news.de
Former Cencora (NYSE: COR) executive lines up stock sale after restricted shares vest - stocktitan.net
Cencora, Inc. (COR) Stock Analysis: A Healthcare Powerhouse with 14.68% Potential Upside - directorstalkinterviews.com
Cencora Executive VP & Chief Legal Officer Elizabeth Campbell Sells 37% Of Holding - simplywall.st
Extending capacity through alternative solutions: The rise of third-party capital - munichre.com
Cencora (COR) Earnings History & Trends - 24/7 Wall St.
Elizabeth S Campbell Takes Money Off The Table, Sells $3.66M In Cencora Stock - benzinga.com
Is Cencora (COR) Still Undervalued Following Its Board Resignation News? - sahmcapital.com
Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant With A 16% Upside Potential - directorstalkinterviews.com
Paralel Advisors LLC Purchases New Position in Cencora, Inc. $COR - MarketBeat
Silvant Capital Management LLC Invests $11.93 Million in Cencora, Inc. $COR - MarketBeat
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Sahm
Cencora Inc (CCOR) 재무 분석
Cencora Inc (CCOR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.48%
0.62%
자본화:
|
볼륨(24시간):